Celldex Therapeutics Inc (CLDX)
SG&A Expense Growth
14.45%
Quarterly · Period ending:
CLDX SG&A Expense Growth
Latest reported14.45%period ending
Latest reported14.45%period ending
CLDX Quarterly SG&A Growth (QoQ) (0.00% → 14.45%)
Latest values, visible window
High-resolution chart · PNG
CLDX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.4467% | |
| -3.8142% | |
| 11.3887% | |
| 2.839% | |
| -3.9649% | |
| 5.4273% | |
| 2.0788% | |
| 10.1446% | |
| 0.2746% | |
| 3.0684% | |
| 7.4322% | |
| 13.8485% | |
| 8.75% | |
| 0.6213% | |
| 1.0412% | |
| -8.7084% | |
| 3.5161% | |
| 10.7355% | |
| 7.2153% | |
| 35.1835% | |
| 4.4892% | |
| 13.7455% | |
| -0.467% | |
| 3.1746% | |
| -3.7643% | |
| 13.8863% | |
| -5.407% | |
| -12.9222% | |
| -20.1797% | |
| 13.0194% | |
| 16.389% | |
| -33.784% | |
| 0.5006% | |
| -5.1069% | |
| 10.2507% | |
| -18.1818% | |
| -9.6141% | |
| -39.4201% | |
| 71.6978% | |
| -10.7831% | |
| -16.2996% | |
| -15.9639% | |
| 30.4937% | |
| 3.7023% | |
| 34.4063% | |
| -2.5604% | |
| 24.8801% | |
| 4.5331% | |
| 4.474% | |
| -2.0312% | |
| 30.7155% | |
| 4.8959% | |
| 8.6998% | |
| 18.6838% | |
| -6.7372% | |
| 27.7603% | |
| -4.2296% | |
| -1.1519% | |
| 3.1236% | |
| 1.4732% | |
| -6.119% | |
| -7.5194% | |
| 6.5675% | |
| -6.5612% | |
| -8.6067% | |
| -55.8274% | |
| 66.7013% | |
| 9.6554% | |
| 5.0803% | |
| 14.3511% | |
| -30.5309% | |
| -8.6723% | |
| 51.8579% | |
| 9.1507% | |
| 38.9064% | |
| 19.6951% | |
| -18.5596% | |
| -11.26% | |
| 27.1359% | |
| -14.0938% | |
| 6.4711% | |
| 20.3143% | |
| -1.0501% | |
| -10.2514% | |
| 8.7861% | |
| -0.5127% | |
| 33.2404% | |
| 1.6461% | |
| -1.7336% | |
| -4.3172% | |
| -5.1486% | |
| 5.3266% | |
| 10.3699% | |
| -12.0881% | |
| 5.092% | |
| -21.4459% | |
| 42.297% | |
| -6.2826% | |
| -4.2597% | |
| 11.2355% |